News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lev Pharmaceuticals, Inc. to Present at the Needham & Co. 7th Annual Biotechnology and Medical Technology Conference


6/5/2008 9:17:07 AM

NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., chief executive officer of Lev will present at the Needham & Co. Biotechnology and Medical Technology Conference, being held June 11-12 at The New York Palace Hotel, New York, NY. Dr. Schein will present a corporate progress report, including an update on the Company's lead product candidate, Cinryze™ [C1 inhibitor (human)]. The Lev presentation is scheduled to begin at 10:30 a.m. Eastern Standard Time on Wednesday, June 11th.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES